Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.

Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ; AtheroGene Investigators.

N Engl J Med. 2003 Oct 23;349(17):1605-13.

2.

Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.

Schnabel R, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Torzewski M, Lubos E, Bickel C, Cambien F, Tiret L, Münzel T, Blankenberg S.

J Am Coll Cardiol. 2005 May 17;45(10):1631-7. Epub 2005 Apr 25.

3.

Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies.

Flores-Mateo G, Carrillo-Santisteve P, Elosua R, Guallar E, Marrugat J, Bleys J, Covas MI.

Am J Epidemiol. 2009 Jul 15;170(2):135-47. doi: 10.1093/aje/kwp112. Epub 2009 May 22.

PMID:
19465742
4.

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Ridker PM, Hennekens CH, Buring JE, Rifai N.

N Engl J Med. 2000 Mar 23;342(12):836-43.

5.

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.

Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, Wiedermann CJ, Oberthaler S, Xu Q, Witztum JL, Tsimikas S.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1788-95. Epub 2007 May 31.

7.

Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.

Roman RM, Camargo PV, Borges FK, Rossini AP, Polanczyk CA.

Coron Artery Dis. 2010 May;21(3):129-36. doi: 10.1097/MCA.0b013e328333f50d.

PMID:
20305551
8.

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.

Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T.

Circulation. 2001 Nov 27;104(22):2673-8. Erratum in: Circulation. 2003 Jul 29;108(4):500.

9.

Serum iron level, coronary artery disease, and all-cause mortality in older men and women.

Corti MC, Guralnik JM, Salive ME, Ferrucci L, Pahor M, Wallace RB, Hennekens CH.

Am J Cardiol. 1997 Jan 15;79(2):120-7.

PMID:
9193009
10.

Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.

Okura T, Higaki J, Kurata M, Irita J, Miyoshi K, Yamazaki T, Hayashi D, Kohro T, Nagai R; Japanese Coronary Artery Disease Study Investigators.

Circ J. 2009 May;73(5):885-91. Epub 2009 Mar 31.

11.

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.

Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.

J Am Coll Cardiol. 2006 May 2;47(9):1850-7. Epub 2006 Apr 19.

12.

Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.

Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.

Coron Artery Dis. 2008 May;19(3):187-93. doi: 10.1097/MCA.0b013e3282f399e2.

PMID:
18418236
13.

Effect of walnut-enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra CHD-risk factor.

Canales A, Benedí J, Nus M, Librelotto J, Sánchez-Montero JM, Sánchez-Muniz FJ.

J Am Coll Nutr. 2007 Jun;26(3):225-32.

PMID:
17634167
14.

Low glutathione reductase and peroxidase activity in age-related macular degeneration.

Cohen SM, Olin KL, Feuer WJ, Hjelmeland L, Keen CL, Morse LS.

Br J Ophthalmol. 1994 Oct;78(10):791-4.

15.

B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.

Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S.

J Am Coll Cardiol. 2006 Feb 7;47(3):552-8. Epub 2006 Jan 18.

16.

Circulating endothelial progenitor cells and cardiovascular outcomes.

Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G.

N Engl J Med. 2005 Sep 8;353(10):999-1007.

17.
18.

Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.

van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH.

Am J Cardiol. 2006 Jun 15;97(12):1697-701. Epub 2006 Apr 21.

PMID:
16765116
19.

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators.

Circulation. 2007 Mar 27;115(12):1528-36. Epub 2007 Mar 19.

Supplemental Content

Support Center